PT - JOURNAL ARTICLE AU - Papangelou, Christina AU - Kyriakidis, Konstantinos AU - Natsiavas, Pantelis AU - Chouvarda, Ioanna AU - Malousi, Andigoni TI - Reliable machine learning models in genomic medicine using conformal prediction AID - 10.1101/2024.09.09.24312995 DP - 2024 Jan 01 TA - medRxiv PG - 2024.09.09.24312995 4099 - http://medrxiv.org/content/early/2024/09/19/2024.09.09.24312995.short 4100 - http://medrxiv.org/content/early/2024/09/19/2024.09.09.24312995.full AB - Machine learning and genomic medicine are the mainstays of research in delivering personalized healthcare services for disease diagnosis, risk stratification, tailored treatment, and prediction of adverse effects. However, potential prediction errors in healthcare services can have life-threatening impact, raising reasonable skepticism about whether these applications are beneficial in real-world clinical practices. Conformal prediction is a versatile method that mitigates the risks of singleton predictions by estimating the uncertainty of a predictive model. In this study, we investigate potential applications of conformalized models in genomic medicine and discuss the challenges towards bridging genomic medicine applications with clinical practice. We also demonstrate the impact of a binary transductive model and a regression-based inductive model in predicting drug response and the performance of a multi-class inductive predictor in addressing distribution shifts in molecular subtyping. The main conclusion is that as machine learning and genomic medicine are increasingly infiltrating healthcare services, conformal prediction has the potential to overcome the safety limitations of current methods and could be effectively integrated into uncertainty-informed applications within clinical environments.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study did not receive any fundingAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Gene Expression Omnibus (https://www.ncbi.nlm.nih.gov/geo/)I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesThe data and code used in this work are available at: https://github.com/BiolApps/ConformalPrediction